Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Benedict16thon May 16, 2020 5:50pm
73 Views
Post# 31038527

RE:ROW Developments ... opinion piece

RE:ROW Developments ... opinion pieceBetter hope that GBT has many new gang buster drugs in the pipeline  coming  soon to market and they can be sold worldwide not just LATAM. Otherwise all GUD sharehoder  will be toasted.  This deal may save JG or could be the final nail/blunder. I follow the LATAM countries very close and I have travled to all of them. Currenlty because of covid-19 all of them are in economic shanbles/disaster for Years to come  with  no economic sunrise anytime soon.  With covid-19 we catch the economic cold they get the economic heart attack. The only positive is that it will be cheap to travel there when the skies open up again. 
This deal will define JG legacy.  He has been kind of coy talking bout GBT. The market so far does not like it and could not care less about JG long ago past succes regarless how many time and how long JG sings it. There has been lots of $$$ been made in the biotech sphere in the last three months but not this one. This one is the only one I have not made money and barely break even I wander why? Cash is king but only with construtive smart actions. For the past three months W Buffet has been making tens of billions of Dollars trades. JG ....Nada ....zero
Bullboard Posts